Last reviewed · How we verify
Blood draw for the laboratory assessment — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Blood draw for the laboratory assessment (Blood draw for the laboratory assessment) — Sanofi. Blood draw for laboratory assessment involves the collection of blood samples for diagnostic testing.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood draw for the laboratory assessment TARGET | Blood draw for the laboratory assessment | Sanofi | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood draw for the laboratory assessment CI watch — RSS
- Blood draw for the laboratory assessment CI watch — Atom
- Blood draw for the laboratory assessment CI watch — JSON
- Blood draw for the laboratory assessment alone — RSS
Cite this brief
Drug Landscape (2026). Blood draw for the laboratory assessment — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-draw-for-the-laboratory-assessment. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab